Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,420.00
+80.00 (1.09%)
Mar 28, 2025, 3:30 PM KST
9.76%
Market Cap 431.38B
Revenue (ttm) 53.48B
Net Income (ttm) 17.80B
Shares Out 58.14M
EPS (ttm) 304.95
PE Ratio 24.33
Forward PE n/a
Dividend 50.00 (0.68%)
Ex-Dividend Date Dec 27, 2024
Volume 1,315,066
Average Volume 1,041,216
Open 7,300.00
Previous Close 7,340.00
Day's Range 7,210.00 - 7,530.00
52-Week Range 4,250.00 - 8,010.00
Beta 0.59
RSI 59.23
Earnings Date Mar 19, 2025

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2003
Employees 102
Stock Exchange KOSDAQ
Ticker Symbol 099430
Full Company Profile

Financial Performance

In 2023, Bio Plus's revenue was 65.04 billion, an increase of 14.68% compared to the previous year's 56.72 billion. Earnings were 25.58 billion, an increase of 21.02%.

Financial Statements

News

There is no news available yet.